Charles Clift
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Pharmaceutical Economics and Policy 6
- Health Systems, Economic Evaluations, Quality of Life 2
-
- Antibiotic Use and Resistance 5
- Co-authors
- David Salisbury (1 shared paper)John‐Arne Røttingen (5 shared papers)Kevin Outterson (4 shared papers)Chantal Morel (3 shared papers)Anthony D. So (3 shared papers)Unni Gopinathan (3 shared papers)John-Arne Røttingen (1 shared paper)Elías Mossialos (1 shared paper)
- Journals
- Development Policy Review (2 papers)The Journal of Law Medicine & Ethics (1 paper)PLoS Medicine (1 paper)Vaccine (1 paper)IDS Bulletin (1 paper)
- Partner nations
- United KingdomUnited StatesNorway
In The Last Decade
Charles Clift
26 papers receiving 210 citations
Peers
Comparison fields: 5 of 78
- Applied Microbiology and Biotechnology 72
- Molecular Medicine 36
- Development 10
- Health 19
- Economics and Econometrics 60
Countries citing papers authored by Charles Clift
This map shows the geographic impact of Charles Clift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Clift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Clift more than expected).
Fields of papers citing papers by Charles Clift
This network shows the impact of papers produced by Charles Clift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Clift. The network helps show where Charles Clift may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Clift, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 35 | |
| 2 | Averting the AMR crisis: What are the avenues for policy action for countries in Europe? | 2019 | 26 |
| 3 | 2017 | 25 | |
| 4 | 2011 | 22 | |
| 5 | Towards a new global business model for antibiotics: delinking revenues from sales. | 2015 | 15 |
| 6 | The Role of the World Health Organization in the International System | 2013 | 14 |
| 7 | 1988 | 10 | |
| 8 | 2015 | 9 | |
| 9 | 2008 | 8 | |
| 10 | 1970 | 7 | |
| 11 | 2018 | 7 | |
| 12 | STEEL BUILDING DAMAGE FROM THE CHRISTCHURCH EARTHQUAKE SERIES OF 2010/2011 | 2011 | 7 |
| 13 | What's the World Health Organization For? | 2015 | 6 |
| 14 | Data protection and data exclusivity in pharmaceuticals and agrochemicals. | 2007 | 5 |
| 15 | 1981 | 5 | |
| 16 | An International Legal Framework to Address Antimicrobial Resistance | 2015 | 5 |
| 17 | 2019 | 4 | |
| 18 | 1971 | 3 | |
| 19 | 1980 | 3 | |
| 20 | 1980 | 2 |
About Charles Clift
Charles Clift is a scholar working on Economics and Econometrics, Applied Microbiology and Biotechnology, Public Health, Environmental and Occupational Health, Communication and General Health Professions, having authored 26 papers that have together received 227 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (6 papers), Antibiotic Use and Resistance (5 papers), Global Public Health Policies and Epidemiology (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Intellectual Property and Patents (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Pneumonia and Respiratory Infections (2 papers) and Media Studies and Communication (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (72 citations), Molecular Medicine (36 citations), Development (10 citations), Health (19 citations) and Economics and Econometrics (60 citations). Charles Clift has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include David Salisbury, John‐Arne Røttingen, Kevin Outterson, Chantal Morel, Anthony D. So, Unni Gopinathan, John-Arne Røttingen, Elías Mossialos, Michael Anderson and Kai Schulze. Their work appears in journals such as Development Policy Review, The Journal of Law Medicine & Ethics, PLoS Medicine, Vaccine and IDS Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.